To our community: Due to circumstances surrounding COVID-19, Clinical Research IO had to make the difficult decision to discontinue funding for Caretalk. We've decided to leave the website up as a resource for the community. Thank you so much to everyone who made this possible, and please enjoy!

An Open-label, 2-Period, Fixed-sequence, Phase 1 Study in Healthy Volunteers to Evaluate the Effect of Itraconazole, a Potent CYP3A Inhibitor, on the Pharmacokinetics of IW-1973

SPONSORED BY Ironwood Pharmaceuticals

Clinical Study Identifier: iw-1973

Caretalk keeps your information private.

To help you apply, Caretalk securely shares only the information you enter in this form with the researchers conducting this study. See our Privacy Policy for more information.

Even if you don't qualify to be a part of this particular study, please check back - there are many new studies each day who need people like you!

Similar Clinical Trials

Trial Sponsor Location Status Start Date Follow
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Add-on Study of MLR 1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy Melior Pharmaceuticals Enrolling 9/01/2017
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Dose Cohort Study to Evaluate the Efficacy and Safety of Twelve Once-weekly Subcutaneous Doses of PB-119 to Patients With Type 2 Diabetes Mellitus (T2DM) Not Well-controlled by Metformin Monotherapy PegBio Enrolling 6/13/2018
nn9535-4352focus Novo Nordisk Enrolling